Literature DB >> 9760992

Bacterial nonspecific acid phosphohydrolases: physiology, evolution and use as tools in microbial biotechnology.

G M Rossolini1, S Schippa, M L Riccio, F Berlutti, L E Macaskie, M C Thaller.   

Abstract

Bacterial nonspecific acid phosphohydrolases (NSAPs) are secreted enzymes, produced as soluble periplasmic proteins or as membrane-bound lipoproteins, that are usually able to dephosphorylate a broad array of structurally unrelated substrates and exhibit optimal catalytic activity at acidic to neutral pH values. Bacterial NSAPs are monomeric or oligomeric proteins containing polypeptide components with an M(r) of 25-30 kDa. On the basis of amino acid sequence relatedness, three different molecular families of NSAPs can be distinguished, indicated as molecular class A, B and C, respectively. Members of each class share some common biophysical and functional features, but may also exhibit functional differences. NSAPs have been detected in several microbial taxa, and enzymes of different classes can be produced by the same bacterial species. Structural and phyletic relationships exist among the various bacterial NSAPs and some other bacterial and eucaryotic phosphohydrolases. Current knowledge on bacterial NSAPs is reviewed, together with analytical tools that may be useful for their characterization. An overview is also presented concerning the use of bacterial NSAPs in biotechnology.

Mesh:

Substances:

Year:  1998        PMID: 9760992     DOI: 10.1007/s000180050212

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  42 in total

1.  Legionella pneumophila major acid phosphatase and its role in intracellular infection.

Authors:  V Aragon; S Kurtz; N P Cianciotto
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

2.  Expression, purification and crystallization of an atypical class C acid phosphatase from Mycoplasma bovis.

Authors:  Harkewal Singh; Thomas J Reilly; Michael J Calcutt; John J Tanner
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-09-30

3.  Isolation, cloning, and expression of an acid phosphatase containing phosphotyrosyl phosphatase activity from Prevotella intermedia.

Authors:  X Chen; T Ansai; S Awano; T Iida; S Barik; T Takehara
Journal:  J Bacteriol       Date:  1999-11       Impact factor: 3.490

4.  Lipoprotein e (P4) of Haemophilus influenzae: role in heme utilization and pathogenesis.

Authors:  Daniel J Morton; Ann Smith; Timothy M VanWagoner; Thomas W Seale; Paul W Whitby; Terrence L Stull
Journal:  Microbes Infect       Date:  2007-04-05       Impact factor: 2.700

5.  Conversion of flavodoxin from holoenzyme to apoprotein during growth phase changes in Helicobacter pylori.

Authors:  Hirofumi Shimomura; Shunji Hayashi; Kenji Yokota; Keiji Oguma; Yoshikazu Hirai
Journal:  J Bacteriol       Date:  2007-04-20       Impact factor: 3.490

6.  Crystallization of recombinant Haemophilus influenzae e (P4) acid phosphatase.

Authors:  Zhonghui Ou; Richard L Felts; Thomas J Reilly; Jay C Nix; John J Tanner
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-04-21

7.  Phosphorylation of nucleosides by the mutated acid phosphatase from Morganella morganii.

Authors:  Y Mihara; T Utagawa; H Yamada; Y Asano
Journal:  Appl Environ Microbiol       Date:  2000-07       Impact factor: 4.792

8.  Outer membrane lipoprotein e (P4) of Haemophilus influenzae is a novel phosphomonoesterase.

Authors:  T J Reilly; D L Chance; A L Smith
Journal:  J Bacteriol       Date:  1999-11       Impact factor: 3.490

9.  Crystal Structures of the histidine acid phosphatase from Francisella tularensis provide insight into substrate recognition.

Authors:  Harkewal Singh; Richard L Felts; Jonathan P Schuermann; Thomas J Reilly; John J Tanner
Journal:  J Mol Biol       Date:  2009-10-21       Impact factor: 5.469

10.  The fusidic acid stimulon of Staphylococcus aureus.

Authors:  Alejandro Delgado; Shahrear Zaman; Arunachalam Muthaiyan; Vijayaraj Nagarajan; Mohamed O Elasri; Brian J Wilkinson; John E Gustafson
Journal:  J Antimicrob Chemother       Date:  2008-09-10       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.